XBIOTECH INC. Contract Liability (Deferred Revenue)
XBIOTECH INC. (XBIT) had Contract Liability (Deferred Revenue) of $0 as of 2020-12-31, per its 10-K filed 2021-03-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2021-03-16
- 2020-12-31: Contract with Customer, Liability, Current $0.00.
- 2020-09-30: Contract with Customer, Liability, Current $0.00.
- 2020-06-30: Contract with Customer, Liability, Current $0.00.
- 2019-12-31: Contract with Customer, Liability, Current $4.50M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-16 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 |
| 2019-12-31 | $4.50M 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |